The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(6-amino-5-(4-oxo-3,4-dihydroquinazolin-7-yl)pyridin-3-yl)-N-cyclopropyl-3-fluoro-N-methylbenzenesulfonamide ID: ALA4871334
PubChem CID: 137104177
Max Phase: Preclinical
Molecular Formula: C23H20FN5O3S
Molecular Weight: 465.51
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(=O)[nH]cnc4c3)c2)c(F)c1
Standard InChI: InChI=1S/C23H20FN5O3S/c1-29(15-3-4-15)33(31,32)16-5-7-17(20(24)10-16)14-8-19(22(25)26-11-14)13-2-6-18-21(9-13)27-12-28-23(18)30/h2,5-12,15H,3-4H2,1H3,(H2,25,26)(H,27,28,30)
Standard InChI Key: KQHLACSPINNCQV-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
9.8025 -7.3568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3458 -6.0997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8000 -8.9985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5121 -7.7673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0930 -10.2264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0638 -6.5091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2256 -7.3566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5181 -10.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3620 -7.7483 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2256 -6.5345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3434 -5.2966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0968 -8.5887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9390 -6.1201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8025 -6.5353 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8035 -9.8206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9416 -7.7610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0968 -7.7668 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0720 -7.3334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0888 -11.0487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5195 -11.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8005 -11.4599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5121 -8.5898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6405 -6.5232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6486 -7.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8058 -12.2771 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.1007 -12.6902 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1059 -13.5074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3904 -12.2862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9760 -11.5867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5720 -12.2970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3873 -9.8144 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.5161 -12.6811 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7980 -13.0916 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24 9 1 0
19 21 2 0
23 24 2 0
17 1 1 0
16 24 1 0
23 2 1 0
3 12 1 0
4 7 1 0
8 20 2 0
18 6 1 0
12 17 2 0
5 19 1 0
23 13 1 0
20 21 1 0
13 10 2 0
9 18 2 0
1 4 2 0
1 14 1 0
10 7 1 0
15 5 2 0
22 3 2 0
2 11 2 0
6 2 1 0
15 3 1 0
8 15 1 0
4 22 1 0
7 16 2 0
21 25 1 0
25 26 1 0
26 27 1 0
26 28 1 0
29 28 1 0
30 29 1 0
28 30 1 0
5 31 1 0
25 32 2 0
25 33 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 465.51Molecular Weight (Monoisotopic): 465.1271AlogP: 3.16#Rotatable Bonds: 5Polar Surface Area: 122.04Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.20CX Basic pKa: 5.88CX LogP: 2.23CX LogD: 2.22Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.47Np Likeness Score: -1.26
References 1. (2020) STK4 inhibitors for treatment of hematologic malignancies,